Key points – Ibrutinib induces a rapid, dramatic and sustained response in MCL patient with symptomatic CNS relapse. Ibrutinib penetration through the blood-brain barrier was confirmed using plasma and CSF pharmacokinetic analyses. (Abstract only)
Home / Resource Library / Activity with ibrutinib in mantle cell lymphoma patients with central nervous system relapse